Table 1.
Patient Groups
Patient Groups | Sex (M:F) | HLAA2+ | Genotype 1 | Age (y) | HCV RNA (IU/ml) | ALT (IU/ml) | Albumin (g/dl) | Bilirubin (mg/dl) | Platelets (×1000/mm 3) |
---|---|---|---|---|---|---|---|---|---|
Median values | |||||||||
A. Acute (n=10) | 7:3 | 7/10 | 7/10 | 35 | 4,000,000 | 281 | 4.4 | 1.8 | 224 |
C. Chronic | |||||||||
Stable (n=11) | 11:0 | 11/11 | 9/11 | 55 | 850,000 | 36 | 4.3 | 0.6 | 244 |
Transplanted (n=16) | 14:2 | 8/16 | 16/16 | 53 | 415,500 | 53 | 2.4 | 2.8 | 93 |
R. Resolved (n=8) | 8:0 | 8/8 | - | 55 | 0 | 23 | 4.5 | 0.6 | 232 |
H. Healthy controls (n=12) | 9:3 | 4/12 | - | 50 | 0 | 28 | 4.4 | 0.6 | 250 |